TrialESMO open2023

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study.

E Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.